Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

Peer Review reports

Original Submission
4 Sep 2018	Submitted	Original manuscript
19 Sep 2018	Author responded	Author comments - Carolina Silveira
Resubmission - Version 2
19 Sep 2018	Submitted	Manuscript version 2
29 Oct 2018	Author responded	Author comments - Carolina Silveira
Resubmission - Version 3
29 Oct 2018	Submitted	Manuscript version 3
Publishing
1 Feb 2019	Editorially accepted
9 Feb 2019	Article published	10.1186/s12883-019-1252-3

Back to article page